FDA Drug recall D-0800-2020
Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles, Entropic Labs UPC#: 651074545302
- FDA Drug
- Class II
- terminated
- Published 2020-01-29
On 2020-01-29 the FDA classified a Class II recall of Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles, Entropic Labs UPC#: 651074545302 by Tuscano And Delucia Group Dba Entropic Labs, citing marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs).
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0800-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-08-24 |
| Published | 2020-01-29 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Tuscano And Delucia Group Dba Entropic Labs |
| Distribution | US |
Product
Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles, Entropic Labs UPC#: 651074545302
Reason
Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs)
Identifiers
| upc | 651074545302 |
|---|---|
| code_info | All lots |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0800-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.